HROW Harrow, Inc.

HROW Harrow, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Desk view

Watchinglow conviction
Basis Logged decision
Updated

Market read

Scan convergence 1 scan as of 2026-10-16 1 bear converging

POC $39.16 · VWAP $39.22 · -30.4% vs 12m avg buyer

collapse vol: normalgaps: stablechurn: quiet as of

Insiders quiet 0 buy / 0 sell · Form 4, 90d

Coverage

1 watchlist

Watchlists @healthcare

HROW Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist HROW belongs to, members best 30-day change first — HROW highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings HROW reports in 23 days Nov 9

Last report Aug 10

Harrow furnished its earnings release to the SEC on August 10, 2026 (8-K, Item 2.02) and filed its 10-Q for the quarter ended June 30, 2026 the same day. No figures from these filings are recorded here.

full note →

Against street estimates

How HROW's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 10 · projection Oct 16

Result
Aug 10 -0.24-0.46-91.7%Miss
May 11 -0.33-0.74-124.2%Miss
Mar 2 0.480.27-43.7%Miss
Nov 10 '25 0.290.33 GAAP ≠ +13.8%Beat
Aug 11 '25 0.040.24 GAAP ≠ +585.7%Beat
May 8 '25 0.01-0.38-5797.1%Miss
Mar 27 '25 0.130.40+207.7%Beat
Nov 13 '24 0.07-0.05-171.4%Miss

Recent news

Headlines about HROW from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.

pulled 14 days ago · Oct 3

Types
Aug 10 Catalyst HROW earnings